» Articles » PMID: 11238892

Change of the Death Pathway in Senescent Human Fibroblasts in Response to DNA Damage is Caused by an Inability to Stabilize P53

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2001 Mar 10
PMID 11238892
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

The cellular function of p53 is complex. It is well known that p53 plays a key role in cellular response to DNA damage. Moreover, p53 was implicated in cellular senescence, and it was demonstrated that p53 undergoes modification in senescent cells. However, it is not known how these modifications affect the ability of senescent cells to respond to DNA damage. To address this question, we studied the responses of cultured young and old normal diploid human fibroblasts to a variety of genotoxic stresses. Young fibroblasts were able to undergo p53-dependent and p53-independent apoptosis. In contrast, senescent fibroblasts were unable to undergo p53-dependent apoptosis, whereas p53-independent apoptosis was only slightly reduced. Interestingly, instead of undergoing p53-dependent apoptosis, senescent fibroblasts underwent necrosis. Furthermore, we found that old cells were unable to stabilize p53 in response to DNA damage. Exogenous expression or stabilization of p53 with proteasome inhibitors in old fibroblasts restored their ability to undergo apoptosis. Our results suggest that stabilization of p53 in response to DNA damage is impaired in old fibroblasts, resulting in induction of necrosis. The role of this phenomenon in normal aging and anticancer therapy is discussed.

Citing Articles

Marizomib Promotes Senescence or Long-Term Apoptosis in Melanoma Cancer Cells.

Piskorz W, Kretowski R, Cechowska-Pasko M Molecules. 2024; 29(23).

PMID: 39683813 PMC: 11643135. DOI: 10.3390/molecules29235652.


Impacts of Senolytic Phytochemicals on Gut Microbiota: A Comprehensive Review.

Kim H, Jung C J Microbiol Biotechnol. 2024; 34(11):2166-2172.

PMID: 39603836 PMC: 11637817. DOI: 10.4014/jmb.2408.08032.


Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence?.

Liu Y, Lomeli I, Kron S Cells. 2024; 13(15.

PMID: 39120312 PMC: 11312217. DOI: 10.3390/cells13151281.


Effects of high glucose and severe hypoxia on the biological behavior of mesenchymal stem cells at various passages.

Almahasneh F, Abu-El-Rub E, Khasawneh R, Almazari R World J Stem Cells. 2024; 16(4):434-443.

PMID: 38690519 PMC: 11056633. DOI: 10.4252/wjsc.v16.i4.434.


Cellular senescence and wound healing in aged and diabetic skin.

Kita A, Yamamoto S, Saito Y, Chikenji T Front Physiol. 2024; 15:1344116.

PMID: 38440347 PMC: 10909996. DOI: 10.3389/fphys.2024.1344116.


References
1.
Afshari C, Vojta P, Annab L, Futreal P, Willard T, Barrett J . Investigation of the role of G1/S cell cycle mediators in cellular senescence. Exp Cell Res. 1993; 209(2):231-7. DOI: 10.1006/excr.1993.1306. View

2.
El-Deiry W, Tokino T, Velculescu V, Levy D, Parsons R, Trent J . WAF1, a potential mediator of p53 tumor suppression. Cell. 1993; 75(4):817-25. DOI: 10.1016/0092-8674(93)90500-p. View

3.
Dulic V, Kaufmann W, Wilson S, Tlsty T, Lees E, Harper J . p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell. 1994; 76(6):1013-23. DOI: 10.1016/0092-8674(94)90379-4. View

4.
Bond J, Wyllie F, Wynford-Thomas D . Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene. 1994; 9(7):1885-9. View

5.
Thyss A, Saudes L, Otto J, Creisson A, Gaspard M, Dassonville O . Renal tolerance of cisplatin in patients more than 80 years old. J Clin Oncol. 1994; 12(10):2121-5. DOI: 10.1200/JCO.1994.12.10.2121. View